Adient Medical Inc.
Absorbable vascular filter for pulmonary embolism prevention
- Sector
- Medtech
- Headquarters
- PEARLAND, TX
- Founded
- 2012
- Latest Form D
- $14.3M, Oct 2022
- Total capital
- $24.5M
- Federal grants
- $6.2M
- 5 awards · 2015–2018
- Rank in peer group#130 of 477
- Private capital raised
- $18.2M
- 4 Form D · last Oct 2022
- 49 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 9 pending · first 2018
- Rank in peer group#99 of 477
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$14.3M
- Private capital raisedForm D · SEC · 3rd filing$711K
- Federal grantHealth and Human S · Phase II · Clinical Evaluation of a Resorbable Vena Cava Filter$1.2M
- Private capital raisedForm D · SEC · 2nd filing$1.7M
- Federal grantHealth and Human S · Phase II · Clinical Evaluation of a Resorbable Vena Cava Filter$1.8M
- Federal grantHealth and Human S · Phase II · Clinical Evaluation of a Resorbable Vena Cava Filter$1.8M
- Private capital raisedForm D · SEC · 1st filing$1.5M
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase II · Resorbable Inferior Vena Cava Filter$621K
- Federal grantHealth and Human S · Phase II · Resorbable Inferior Vena Cava Filter$872K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
16months
from Adient Medical Inc.’s first federal award to its first private round.
- First federal award · Mar 2015
- Health and Human S · $872K
- First Form D · Jul 2016
- $1.5M · 1st Form D
- Awards before first raise
- 2 awards
An association in public records, not a cause or a prediction.
Standing among 477 peers
Line = medianMedtech · Device
- Federal grants#130 · top 27%
- Granted patents#99 · top 21%
- Linked publications#25 · top 5%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Mitchell EggersResearcherExecutive Officer, DirectorLinked by 2 patents · $6.2M in grants as PI
- Michael HoganDirectorNamed in SEC Form D filings
- Robert MitchellDirectorNamed in SEC Form D filings
- Robert TucciDirectorNamed in SEC Form D filings
What it has protected
USPTO · 3 granted of 12- PendingDelivery System For A Medical DeviceUSPTOApplication 17731630
- PendingAbsorbable Vascular FilterUSPTOApplication 16659536
- GrantedMethod And Apparatus For Deploying And Retrieving Objects In A CavityUSPTOUS 10,524,892
Show all 12 patent records
- Delivery System For A Medical DeviceNov 3, 2022 · Application 17731630Pending
- Absorbable Vascular FilterApr 16, 2020 · Application 16659536Pending
- Method And Apparatus For Deploying And Retrieving Objects In A CavityJan 7, 2020 · US 10,524,892Granted
- Absorbable Vascular FilterAug 20, 2019 · US 10,383,718Granted
- Method And Apparatus For Deploying And Retrieving Objects In A CavityApr 19, 2018 · Application 15847115Pending
- Method And Apparatus For Deploying And Retrieving Objects In A CavityFeb 20, 2018 · US 9,895,215Granted
- Absorbable Vascular FilterAug 17, 2017 · Application 15586123Pending
- Vascular Filter StentJun 2, 2016 · Application 15014975Pending
- Method And Apparatus For Deploying And Retrieving Objects In A CavityApplication PCTUS2017030924Pending
- Absorbable Vascular FilterApplication PCTUS2020056359Pending
- Method And Apparatus For Deploying And Retrieving Objects In A CavityApplication 62331291Pending
- Delivery SystemApplication 63183166Pending
Recent research by its founders
- When migration is not migration20210 cites
- <i>In vivo</i> performance of gold nanoparticle-loaded absorbable inferior vena cava filters in a swine model202021 cites
- First-in-Human Study with Eight Patients Using an Absorbable Vena Cava Filter for the Prevention of Pulmonary Embolism202013 cites
Related companies, and why
- MONOD BIO, INC.Similar federal contract value in Medtech · null in contracts
- Cylerus, Inc.Similar federal contract value in Medtech · null in contracts
- COOLER HEADS CARE INCSimilar federal contract value in Medtech · null in contracts
- Paratus DiagnosticsSimilar federal contract value in Medtech · null in contracts
- LIFE MAGNETICS, INC.Similar federal contract value in Medtech · null in contracts
- CAIRNSURGICAL, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .